D. Gil

发表

Synthetic modification of prostaglandin f(2alpha) indicates different structural determinants for binding to the prostaglandin F receptor versus the prostaglandin transporter.

V. Schuster, D. Woodward, S. Andrews, 2000, Molecular pharmacology.

Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation.

E. Woldemussie, D. Gil, H. A. Krauss, 1997, Investigative ophthalmology & visual science.

Transient allodynia pain models in mice for early assessment of analgesic activity

J. Donello, D. Gil, C. Cheevers, 2008, British journal of pharmacology.

Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.

J. Regan, K. L. Pierce, J. Donello, 1994, Molecular pharmacology.

Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats.

Y. Le, J. Kusari, Meili Zhu, 2011, Investigative ophthalmology & visual science.

Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma.

L. Wheeler, E. Woldemussie, D. Gil, 2001, Survey of ophthalmology.

Cloning of a receptor for prostaglandin F2 alpha from the ovine corpus luteum.

J. Regan, B. Rueda, P. Hoyer, 1995, Endocrinology.

Cloning of human prostanoid receptors.

J. Regan, K. L. Pierce, D. Woodward, 1995, Trends in pharmacological sciences.

Molecular cloning and expression of human EP3 receptors: evidence of three variants with differing carboxyl termini

J. Regan, K. L. Pierce, J. Donello, 1994, British journal of pharmacology.

alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia.

L. Wheeler, J. Donello, M. L. Webster, 2001, The Journal of pharmacology and experimental therapeutics.

Cloning of a Carboxyl-terminal Isoform of the Prostanoid FP Receptor*

J. Regan, P. Hoyer, K. L. Pierce, 1997, The Journal of Biological Chemistry.

The pharmacology of bimatoprost (Lumigan).

R. Lai, L. Wheeler, W. Yang, 2001, Survey of ophthalmology.

Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024)

L. Wheeler, M. Garst, D. Welty, 2003, Journal of Pharmacology and Experimental Therapeutics.

Role of sympathetic nervous system in rat model of chronic visceral pain

J. Donello, E. Al-Chaer, D. Gil, 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Molecular characterization and ocular hypotensive properties of the prostanoid EP2 receptor.

J. Donello, C. E. Fairbairn, D. Woodward, 1995, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Localization of alpha 2-adrenergic receptor subtypes in the anterior segment of the human eye with selective antibodies.

J. Regan, P. Vanscheeuwijck, W. Stamer, 1995, Investigative ophthalmology & visual science.

Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.

B. Wolfe, D. Gil, 1985, The Journal of pharmacology and experimental therapeutics.

Structural basis for the differential RXR & RAR activity of stilbene retinoid analogs

R. Chandraratna, P. Davies, R. Beard, 1994 .

Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.

J. Kusari, D. Gil, E. Padillo, 2010, Investigative ophthalmology & visual science.

&agr;-1-Adrenergic Receptor Agonist Activity of Clinical &agr;-Adrenergic Receptor Agonists Interferes with &agr;-2-Mediated Analgesia

J. Donello, K. Kedzie, D. Gil, 2009, Anesthesiology.

The inflow and outflow of anti-glaucoma drugs.

D. Woodward, D. Gil, 2004, Trends in pharmacological sciences.

Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist.

M. Brann, F. Piu, J. Donello, 2008, European journal of pharmacology.

Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.

J. Kusari, D. Gil, E. Padillo, 2007, Investigative ophthalmology & visual science.

Replacement of the carboxylic acid group of prostaglandin F2α with a hydroxyl or methoxy substituent provides biologically unique compounds

G. Sachs, J. Regan, K. L. Pierce, 2000, British journal of pharmacology.

A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs.

J. Regan, J. Donello, K. Kedzie, 1998, Molecular pharmacology.

(cid:1) -1-Adrenergic Receptor Agonist Activity of Clinical (cid:1) -Adrenergic Receptor Agonists Interferes with (cid:1) -2-Mediated Analgesia

J. Donello, K. Kedzie, D. Gil, 2009 .

Synthesis and pharmacological activity of conformationally restricted, acetylenic retinoid analogs

L. Wheeler, M. Garst, R. Chandraratna, 1995 .

Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert.

B. Wolfe, D. Gil, 1986, The Journal of pharmacology and experimental therapeutics.

DEVELOPMENT OF RAR SUBTYPE SELECTIVE RETINOIDS FOR DERMATOLOGICAL DISEASES

L. Wheeler, S. Nagpal, M. Garst, 1995, European Journal of Medicinal Chemistry.